샘플 요청 목록

 카트 문의
시장보고서
상품코드
1788338

세계의 감시 림프절 생검 시장

Sentinel Node Biopsy
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 203 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

감시 림프절 생검 세계 시장은 2030년까지 13억 달러에 달할 전망

2024년에 8억 2,930만 달러로 추정되는 감시 림프절 생검 세계 시장은 분석 기간인 2024-2030년에 CAGR 7.1%로 성장하여 2030년에는 13억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 외과용 기구는 CAGR 7.9%를 기록하며 분석 기간 종료시에는 7억 3,220만 달러에 달할 것으로 예측됩니다. 이미징제 부문의 성장률은 분석 기간 동안 CAGR 6.2%로 추정됩니다.

미국 시장은 2억 1,800만 달러로 추정, 중국은 CAGR 6.9%로 성장 예측

미국의 감시 림프절 생검 시장은 2024년에 2억 1,800만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 6.9%로서 2030년에는 예측 시장 규모 2억 30만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 6.7%와 5.9%로 예측됩니다. 유럽에서는 독일이 CAGR 5.6%로 성장할 것으로 예측됩니다.

세계의 감시 림프절 생검 시장 - 주요 동향과 촉진요인 정리

감시 림프절 생검이 암 진단에 있어 중요한 절차가 되고 있는 이유는 무엇인가?

감시 림프절 생검(SNB)은 특히 유방암이나 흑색종의 경우 암의 전이 여부를 판단하기 위해 사용되는 최소침습적 수술입니다. SNB는 암세포가 도달할 가능성이 있는 첫 번째 림프절(감시 림프절)을 식별하고 분석함으로써 의사가 림프절 전절제술 없이도 전이를 평가할 수 있도록 도와줍니다. 이 방법은 높은 진단 정확도를 유지하면서 림프부종 등의 합병증을 줄일 수 있어 인기를 끌고 있습니다. 전 세계적으로 암 발병률이 증가하고 조기 발견이 생존율 향상에 중요한 역할을 하는 가운데, 감시 림프절 생검에 대한 수요는 의료 기관 전반에서 증가하고 있습니다. 또한, 영상 진단과 분자진단의 발전으로 SNB의 정확도와 신뢰성이 더욱 향상되고 있습니다.

감시 림프절 생검 기술을 향상시키는 기술 혁신은 어떤 것이 있을까?

최근 방사성 추적자 기술, 형광 유도 수술, 분자 이미징의 발전은 감시 림프절 생검에 혁명을 일으키고 있습니다. 방사성 염료와 형광증백제가 결합된 하이브리드 트레이서를 사용하여 검출률을 향상시키고, 외과의사는 감시 림프절의 위치를 정확하게 파악할 수 있게 되었습니다. AI를 통한 병리 분석은 생검 결과의 정확도를 더욱 높여 더 나은 암 병기 분류와 치료 계획 수립으로 이어지고 있습니다. 또한, 로봇 보조 감시 림프절 생검은 정확도를 높이고 환자의 외상을 최소화하기 위해 연구되고 있습니다. 이러한 기술적 비약적인 발전으로 SNB는 보다 효율적이고 정확도가 높아져 종양학 진료에 널리 활용되고 있습니다.

감시 림프절 생검의 성장을 주도하는 의료 분야는?

유방암 진단은 여전히 감시 림프절 생검의 주요 응용 분야이며, SNB는 조기 유방암 환자의 표준 치료법입니다. 피부과나 종양내과에서도 림프절 전이를 정확하게 평가할 수 있는 SNB를 흑색종 병기 분류에 활용하고 있습니다. 두경부암, 부인과암, 전립선암에 대한 새로운 응용으로 SNB의 사용은 더욱 확대되고 있습니다. 또한, 신흥 시장의 의료 서비스 제공업체들은 종양학 인프라에 대한 투자 증가에 힘입어 암 치료 전략 개선의 일환으로 SNB를 채택하고 있습니다.

감시 림프절 생검 시장의 성장을 가속하는 요인은 무엇인가?

감시 림프절 생검 시장의 성장은 암 발병률 증가, 최소침습적 진단 기술의 채택 증가, 영상 기술의 발전에 힘입어 성장하고 있습니다. 암 조기 발견을 장려하는 정부의 이니셔티브와 종양학 진단에 대한 접근성 향상으로 시장 확대가 더욱 가속화되고 있습니다. 또한 병리학에서 AI와 머신러닝의 통합은 SNB의 정확도를 높이고 종양 전문의와 외과 의사 수요를 촉진하고 있습니다. 정밀의료가 계속 진화하는 가운데, SNB는 맞춤형 암 치료와 예후 진단에 있어 점점 더 중요한 역할을 할 것으로 보입니다.

부문

제품(수술기구, 영상 진단, 진단 키트), 시술(관혈적 수술, 최소침습 수술), 용도(유방암, 대장암, 식도암, 기타), 최종 용도(병원·클리닉, 외래 수술 센터, 진단 센터)

조사 대상 기업 사례

  • BD(Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd(Endomag)
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd(Care Wise)
  • LabLogic Systems Ltd(Care Wise)
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSM 25.08.21

Global Sentinel Node Biopsy Market to Reach US$1.3 Billion by 2030

The global market for Sentinel Node Biopsy estimated at US$829.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Surgical Instruments, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$732.2 Million by the end of the analysis period. Growth in the Imaging Agents segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sentinel Node Biopsy market in the U.S. is estimated at US$218.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$200.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Sentinel Node Biopsy Market - Key Trends & Drivers Summarized

Why Is Sentinel Node Biopsy Becoming A Crucial Procedure In Cancer Diagnostics?

Sentinel node biopsy (SNB) is a minimally invasive surgical procedure used to determine the spread of cancer, particularly in cases of breast cancer and melanoma. By identifying and analyzing the first lymph node (sentinel node) that cancer cells are likely to reach, SNB helps physicians assess metastasis without requiring a full lymph node dissection. This technique is gaining popularity due to its ability to reduce complications such as lymphedema while maintaining high diagnostic accuracy. With cancer rates rising globally and early detection playing a critical role in improving survival rates, the demand for sentinel node biopsy procedures is growing across healthcare institutions. Additionally, advancements in imaging and molecular diagnostics are further improving SNB precision and reliability.

What Technological Innovations Are Enhancing Sentinel Node Biopsy Procedures?

Recent advancements in radiotracer technology, fluorescence-guided surgery, and molecular imaging are revolutionizing sentinel node biopsy. The use of hybrid tracers combining radioactive and fluorescent dyes is improving detection rates, allowing surgeons to precisely locate sentinel lymph nodes. AI-assisted pathology analysis is further enhancing the accuracy of biopsy results, leading to better cancer staging and treatment planning. Additionally, robotic-assisted sentinel node biopsies are being explored to improve precision and minimize patient trauma. These technological breakthroughs are making SNB more efficient, accurate, and widely accessible in oncology practices.

Which Medical Sectors Are Driving The Growth Of Sentinel Node Biopsy?

Breast cancer diagnosis remains the leading application of sentinel node biopsy, with SNB becoming the standard of care for early-stage breast cancer patients. Dermatology and oncology practices are also utilizing SNB for melanoma staging, as it allows for precise assessment of lymph node involvement. Emerging applications in head and neck cancer, gynecologic cancers, and prostate cancer are further expanding the use of SNB. Additionally, healthcare providers in emerging markets are adopting SNB as part of improved cancer care strategies, supported by growing investments in oncology infrastructure.

What Factors Are Fueling The Growth Of The Sentinel Node Biopsy Market?

The growth of the sentinel node biopsy market is being driven by increasing cancer prevalence, rising adoption of minimally invasive diagnostic procedures, and advancements in imaging technology. Government initiatives promoting early cancer detection and improved access to oncology diagnostics are further supporting market expansion. Additionally, the integration of AI and machine learning in pathology is enhancing SNB accuracy, driving demand among oncologists and surgeons. As precision medicine continues to evolve, SNB will play an increasingly crucial role in personalized cancer treatment and prognosis.

SCOPE OF STUDY:

The report analyzes the Sentinel Node Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Surgical Instruments, Imaging Agents, Diagnostic Kits); Procedure (Open Surgery, Minimally Invasive Surgery); Application (Breast Cancer, Colon Cancer, Esophageal Cancer, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health
  • Care Wise
  • Devicor Medical Products, Inc.
  • Devicor Medical Products, Inc.
  • Endomagnetics Ltd (Endomag)
  • Gamma Medical Technology
  • Gamma Probe Technologies
  • GE Healthcare
  • Hologic, Inc.
  • Hologic, Inc.
  • Intramedical Imaging LLC
  • IsoRay Medical
  • KUB Technologies Inc.
  • KUB Technologies Inc.
  • LabLogic Systems Ltd (Care Wise)
  • LabLogic Systems Ltd (Care Wise)
  • LymphaTech
  • Medtronic
  • Navidea Biopharmaceuticals, Inc.
  • Philips Healthcare
  • Senti Biosciences
  • Siemens Healthineers
  • Stryker Corporation
  • Stryker Corporation
  • SurgicEye GmbH
  • SurgicEye GmbH
  • Varay Laborix

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sentinel Node Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Early Cancer Detection Drives Growth in Sentinel Node Biopsy Procedures
    • Surge in Cancer Incidence Rates Expands Market Opportunities for Sentinel Node Biopsy Technologies
    • Technological Advancements in Imaging and Tracers Propel the Accuracy and Effectiveness of Sentinel Node Biopsy
    • Rising Awareness Among Healthcare Providers and Patients of the Benefits of Minimally Invasive Procedures Accelerates Adoption of Sentinel Node Biopsy
    • The Shift Toward Personalized Medicine and Tailored Cancer Treatments Drives Demand for Sentinel Node Biopsy Solutions
    • Increasing Focus on Reducing Surgical Complications and Recovery Times Strengthens the Business Case for Sentinel Node Biopsy
    • Surge in Breast Cancer and Melanoma Cases Drives the Demand for Sentinel Node Biopsy in Oncology Treatments
    • Expansion of Cancer Immunotherapy and Targeted Therapies Fuels Market Growth for Sentinel Node Biopsy Procedures
    • Rising Investment in Advanced Cancer Diagnostics and Staging Technologies Expands Market Potential for Sentinel Node Biopsy
    • Increasing Integration of Artificial Intelligence in Imaging and Diagnostic Technologies Drives Adoption of Sentinel Node Biopsy Solutions
    • Regulatory Support and Approvals for Non-Invasive and Less Invasive Diagnostic Methods Strengthen Demand for Sentinel Node Biopsy Procedures
    • Increasing Preference for Lymph Node Staging Techniques That Minimize Patient Discomfort Drives Adoption of Sentinel Node Biopsy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sentinel Node Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Diagnostic Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Colon Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Colon Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Esophageal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Esophageal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • JAPAN
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • CHINA
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 52: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • EUROPE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Sentinel Node Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • FRANCE
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 70: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: France 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • GERMANY
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Germany 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • UNITED KINGDOM
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Sentinel Node Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Product - Surgical Instruments, Imaging Agents and Diagnostic Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Product - Percentage Breakdown of Value Sales for Surgical Instruments, Imaging Agents and Diagnostic Kits for the Years 2025 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by End-Use - Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Sentinel Node Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Diagnostic Centers for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Procedure - Open Surgery and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Procedure - Percentage Breakdown of Value Sales for Open Surgery and Minimally Invasive Surgery for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Sentinel Node Biopsy by Application - Breast Cancer, Colon Cancer, Esophageal Cancer and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Sentinel Node Biopsy by Application - Percentage Breakdown of Value Sales for Breast Cancer, Colon Cancer, Esophageal Cancer and Others for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제